Pasar al contenido principal

RESONADORES NANOFOTONICOS PARA LA EVALUACION DE INMUNOTERAPIAS CONTRA EL CANCER

PID2023-151524OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIÓ INSTITUT CATALÀ DE NANOCIÈNCIA I NANOTECNOLOGIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

All-dielectric photonic nanoresonators for visible-range biosensing with cell-mimetic functionalization

  • Batool, Razia
  • Singh, Rukmani
  • Sterman, Raquel G.
  • Lechuga, Laura M.
  • Soler, María
All-dielectric nanophotonic sensors are emerging as powerful platforms for high-resolution, label-free detection, exploiting sharp Mie-type resonances in low-loss materials. These sensors offer key advantages over metallic counterparts, including biocompatibility, highly hydrophilic surfaces and negligible heating that preserves delicate biochemical assemblies. While most reported all-dielectric sensors operate in the infrared, where resonances are stronger, translation into the visible spectrum is highly desirable for biological sensing, offering compatibility with standard optical components and enhanced sample interaction. In this work, we present a cost-effective nanofabrication strategy for high-performance silicon-based nanoresonators operating in the visible range and integrated into compact light prism-coupling devices. Using hole-mask colloidal lithography, we reproducibly fabricate short-range ordered silicon nanodisk array sensors with refractometric resonances around 720 nm and narrow bandwidths. We demonstrate a bulk refractometric sensitivity of 543 nm per refractive index unit (nm RIU<sup>−1</sup>) and a detection resolution as low as 10<sup>−6</sup> RIU, superior to analogous nanoplasmonic sensors. Integration of these nanosensors into a small-footprint optofluidic device allows for time-resolved analysis of biochemical interactions in a user-friendly, semi-automated format. Finally, as a proof of concept, we demonstrate their stable and efficient functionalization with supported lipid bilayers as cell membrane-mimicking interfaces for advanced on-chip studies of cell interactions or cell activity monitoring., The research work has been funded through the PRIME project (PID2023-151524OB-I00), funded by MICIU/AEI/ 10.13039/501100011033 and by ERDF/EU. MS acknowledges the economic support of the Ramon y Cajal Grant (RYC2020-029015-I) funded by the AEI/MCIN and the European Union NextGenerationEU/PRTR. The ICN2 is supported by the Severo Ochoa Centres of Excellence Programme, Grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033. ICN2 is funded by the CERCA programme (Generalitat de Catalunya)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evanescent Wave-Based Photonic Biosensors for the Design and Evaluation of Advanced Cancer Immunotherapies

  • Huertas, César S.
  • Lechuga, Laura M.
  • Soler, María
Personalized immunotherapies hold great promise for correcting cellular dysfunction, inhibiting tumor growth, and even achieving durable cancer eradication. However, conventional analytical methods used to design and evaluate immunotherapies often fall short as they typically cannot monitor cell activity in real time, lack multiplexed capabilities for rapid screening, and require complex sample preparation. These limitations impede a full understanding of the dynamic immune responses that drive therapeutic outcomes. Label-free optical biosensors based on evanescent wave interactions provide a compelling alternative, enabling sensitive, noninvasive, and high-resolution analysis of cellular regulation, signaling, and therapy-induced molecular changes. In this perspective, we highlight recent advances in optical biosensor technologies for molecular and cell analysis and explore their potential to accelerate the development, optimization, and precision application of next-generation immunotherapies., Financial support is acknowledged from the PRIME project (PID2023-151524OB-I00), funded by the Spanish Ministry of Science and Innovation (MICIN) through the Spanish Research Agency (AEI), cofunded by the European Regional Development Fund (FEDER, European Union). M.S. acknowledges financial support from the Ramon y Cajal Fellowship (RYC2020-029015-I) funded by the AEI/MCIN, cofounded by the European Social Fund Plus (ESF+, European Union). The ICN2 is supported by the Severo Ochoa Centers of Excellence Program, Grant CEX2021-001214-S, funded by the MCIN/AEI/10.13039.501100011033. ICN2 is funded by the CERCA program (Generalitat de Catalunya)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), Peer reviewed